US 11752164
Bortezomib compositions
granted A61KA61K31/198A61K31/4439
Quick answer
US patent 11752164 (Bortezomib compositions) held by MAIA PHARMACEUTICALS, INC. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MAIA PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/198, A61K31/4439, A61K31/573, A61K31/69